Migralex, Inc.

Developed by world renowned neurologist, Migralex is the only patented analgesic with superior efficacy and a safer profile. 94% IRR, 11.5x Cash, 2.5yr Payback.

  • Stage Full Product Ready
  • Industry Consumer Products
  • Location New York, NY, US
  • Currency USD
  • Website trymigralex.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free